Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD
Targeted therapies are effective cancer treatments when accompanied by accurate diagnostic tests that can help identify patients that will respond to those therapies. The YAP/TAZ-TEAD axis is activated and plays a causal role in several cancer types, and TEAD inhibitors are currently in early-phase...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
MDPI AG
2024
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/1721.1/153660 |